Adimab, LLC

Insider Reports History

Location
Lebanon, NH
Signature
By: /s/ Philip Chase, Chief Executive Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adimab, LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
Invivyd, Inc. 10%+ Owner Common Stock 21,687,906 $85,667,229 $3.95 19 Jan 2024 Direct

Insider Reports Filed by Adimab, LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IVVD Invivyd, Inc. 19 Jan 2024 1 -$19,750,000 4 10%+ Owner 22 Jan 2024, 16:18
IVVD Adagio Therapeutics, Inc. 03 Mar 2022 1 $0 4 Other*, 10%+ Owner 01 Apr 2022, 16:08
IVVD Adagio Therapeutics, Inc. 10 Aug 2021 4 $0 4 10%+ Owner 12 Aug 2021, 21:22
IVVD Adagio Therapeutics, Inc. 05 Aug 2021 0 $0 3 10%+ Owner 05 Aug 2021, 21:14